Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7422-7428
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7422
Figure 3
Figure 3 Genetic testing showed that the presence of a JAK2 (exon 14) V617F mutation. The bone marrow biopsy showed that bone marrow hyperplasia was significantly active, the granulocyte/nucleated red blood cell ratio was normal, and megakaryocytes were common.